{"id":102933,"date":"2026-06-01T16:07:17","date_gmt":"2026-06-01T10:37:17","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=102933"},"modified":"2026-06-01T16:07:18","modified_gmt":"2026-06-01T10:37:18","slug":"nureca-q4-fy26-net-profit-rs-32-31-cr-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/","title":{"rendered":"Nureca Q4 FY26 Results: Net Profit Rs 32.31 Crore, Revenue and Key Financial Highlights"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p><strong><a href=\"https:\/\/univest.in\/user\/stocks\/nureca\/nureca-ltd-share-price-today\">Nureca<\/a> Q4 FY26 results<\/strong> were declared on May 29, 2026. The company reported net profit of Rs 32.31 crore for the quarter ended March 31, 2026, reflecting its operational performance in the January to March 2026 period. Revenue details for the quarter are available in the BSE\/NSE audited filing declared May 29, 2026. Nureca operates in the healthcare devices sector and is listed on Indian stock exchanges. India&#8217;s strong macroeconomic backdrop, including GDP growth above 6.5% and the RBI&#8217;s supportive monetary stance, shaped the operating environment in Q4 FY26.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\">Click Here &#8211; Get Free Investment Predictions<\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#Nureca_Q4_FY26_Financial_Highlights\" title=\"Nureca Q4 FY26 Financial Highlights\">Nureca Q4 FY26 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#Nureca_Q4_FY26_Performance_Analysis\" title=\"Nureca Q4 FY26 Performance Analysis\">Nureca Q4 FY26 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#Key_Business_Factors_in_Q4_FY26\" title=\"Key Business Factors in Q4 FY26\">Key Business Factors in Q4 FY26<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#Revenue_and_Business_Operations\" title=\"Revenue and Business Operations\">Revenue and Business Operations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#Profitability_and_Cost_Management\" title=\"Profitability and Cost Management\">Profitability and Cost Management<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#Sector_and_Macro_Backdrop\" title=\"Sector and Macro Backdrop\">Sector and Macro Backdrop<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#FY27_Outlook\" title=\"FY27 Outlook\">FY27 Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#Nureca_Stock_and_Live_Price\" title=\"Nureca Stock and Live Price\">Nureca Stock and Live Price<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#Key_Risks\" title=\"Key Risks\">Key Risks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#Revenue_and_Demand_Risk\" title=\"Revenue and Demand Risk\">Revenue and Demand Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#Margin_and_Cost_Volatility\" title=\"Margin and Cost Volatility\">Margin and Cost Volatility<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#Regulatory_and_Competitive_Risk\" title=\"Regulatory and Competitive Risk\">Regulatory and Competitive Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#Frequently_Asked_Questions_on_Nureca_Q4_FY26_Results\" title=\"Frequently Asked Questions on Nureca Q4 FY26 Results\">Frequently Asked Questions on Nureca Q4 FY26 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#What_is_Nureca_Q4_FY26_net_profit\" title=\"What is Nureca Q4 FY26 net profit?\">What is Nureca Q4 FY26 net profit?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#What_is_Nureca_Q4_FY26_revenue\" title=\"What is Nureca Q4 FY26 revenue?\">What is Nureca Q4 FY26 revenue?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#When_were_Nureca_Q4_FY26_results_declared\" title=\"When were Nureca Q4 FY26 results declared?\">When were Nureca Q4 FY26 results declared?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#What_dividend_did_Nureca_declare_for_FY26\" title=\"What dividend did Nureca declare for FY26?\">What dividend did Nureca declare for FY26?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#Is_Nureca_a_good_stock_to_buy_after_Q4_FY26_results\" title=\"Is Nureca a good stock to buy after Q4 FY26 results?\">Is Nureca a good stock to buy after Q4 FY26 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/nureca-q4-fy26-net-profit-rs-32-31-cr-results\/#What_is_the_FY27_outlook_for_Nureca\" title=\"What is the FY27 outlook for Nureca?\">What is the FY27 outlook for Nureca?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Nureca_Q4_FY26_Financial_Highlights\"><\/span><strong>Nureca Q4 FY26 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>Q4 FY26<\/th>\n<th>Q4 FY25<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Revenue from Operations (Rs Crore)<\/strong><\/td>\n<td>See BSE Filing<\/td>\n<td>Prior Year<\/td>\n<td>See BSE\/NSE Filing<\/td>\n<\/tr>\n<tr>\n<td><strong>Net Profit (PAT) (Rs Crore)<\/strong><\/td>\n<td>32.31<\/td>\n<td>Prior Year<\/td>\n<td>See BSE\/NSE Filing<\/td>\n<\/tr>\n<tr>\n<td><strong>Reporting Basis<\/strong><\/td>\n<td colspan=\"3\">Standalone \/ Consolidated (see BSE\/NSE filing)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Data sourced from company filings and public disclosures. Always verify from BSE\/NSE audited filings before investment decisions.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Nureca_Q4_FY26_Performance_Analysis\"><\/span><strong>Nureca Q4 FY26 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Nureca Q4 FY26 results<\/strong> reflect performance in the January to March 2026 quarter, the seasonally important fourth quarter of the financial year. Revenue details are available in the BSE\/NSE audited filing. Net profit of Rs 32.31 crore demonstrates the company&#8217;s operational efficiency. The January to March 2026 quarter was characterised by sustained domestic demand recovery, government infrastructure spending, and the RBI&#8217;s supportive monetary policy stance.<\/p>\n<p>India&#8217;s macroeconomic backdrop in Q4 FY26 included GDP growth above 6.5%, central government capex of Rs 11.21 lakh crore budgeted for FY27, and stable inflationary conditions. These factors provided a constructive operating environment for listed companies across sectors during the quarter ended March 31, 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_in_Q4_FY26\"><\/span><strong>Key Business Factors in Q4 FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_and_Business_Operations\"><\/span><strong>Revenue and Business Operations<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Revenue details are available in the BSE\/NSE audited filing. The company&#8217;s operational performance in Q4 FY26 reflects the prevailing demand conditions in its sector. Management commentary from the board meeting on May 29, 2026 provides key insights into volume trends, pricing dynamics, and business strategy for FY27.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Profitability_and_Cost_Management\"><\/span><strong>Profitability and Cost Management<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Net profit of Rs 32.31 crore demonstrates the company&#8217;s operational efficiency. Cost management, raw material trends, and operating leverage are key factors influencing the bottom line. Investors should review the full audited financial statement available on BSE\/NSE for a detailed breakdown of operating expenses and margins.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Sector_and_Macro_Backdrop\"><\/span><strong>Sector and Macro Backdrop<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s Q4 FY26 macro environment was shaped by continued GDP growth, budgeted government capex of Rs 11.21 lakh crore for FY27, and the RBI&#8217;s accommodative policy stance. These structural tailwinds supported business investment, consumer spending, and capital formation across India&#8217;s listed companies during the January to March 2026 quarter.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook\"><\/span><strong>FY27 Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Following the <strong>Nureca Q4 FY26 results<\/strong>, investors will focus on management guidance for FY27. Revenue growth targets, margin improvement initiatives, capital allocation plans, and sector-specific catalysts will be key inputs for FY27 performance assessment. India&#8217;s GDP growth trajectory, domestic demand trends, and global macro conditions will be important external factors shaping the FY27 outlook for Nureca.<\/p>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track live price and daily stock recommendations.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Nureca_Stock_and_Live_Price\"><\/span><strong>Nureca Stock and Live Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Shares of Nureca are listed on Indian stock exchanges. Following the Q4 FY26 results declaration on May 29, 2026, investors should monitor post-results price action, trading volumes, and management commentary. Always consult a SEBI-registered financial advisor before making investment decisions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks\"><\/span><strong>Key Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_and_Demand_Risk\"><\/span><strong>Revenue and Demand Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Any deceleration in India&#8217;s GDP growth, reduction in government capex, or weakening of private consumption could negatively impact demand for Nureca&#8217;s products and services in FY27.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Margin_and_Cost_Volatility\"><\/span><strong>Margin and Cost Volatility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Fluctuations in raw material costs, energy prices, and logistics expenses pose margin risks. Cost escalation without corresponding pricing power could compress profitability from Q4 FY26 levels.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Regulatory_and_Competitive_Risk\"><\/span><strong>Regulatory and Competitive Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Changes in regulatory frameworks, increased competitive pressure from domestic or global peers, and customer concentration risks are key watchpoints for investors in Nureca.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Nureca Q4 FY26 results were declared on May 29, 2026. The company reported net profit of Rs 32.31 crore for the quarter ended March 31, 2026. Revenue details are available in the BSE\/NSE audited filing. Investors should monitor management guidance, sector trends, and BSE\/NSE filings before making investment decisions. Consult a SEBI-registered financial advisor before investing.<\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Nureca_Q4_FY26_Results\"><\/span><strong>Frequently Asked Questions on Nureca Q4 FY26 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Nureca_Q4_FY26_net_profit\"><\/span><strong>What is Nureca Q4 FY26 net profit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nureca Q4 FY26 net profit was Rs 32.31 crore. Results declared May 29, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Nureca_Q4_FY26_revenue\"><\/span><strong>What is Nureca Q4 FY26 revenue?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nureca Q4 FY26 revenue details are available in the BSE\/NSE audited filing declared May 29, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"When_were_Nureca_Q4_FY26_results_declared\"><\/span><strong>When were Nureca Q4 FY26 results declared?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Nureca Q4 FY26 results were declared on May 29, 2026 at the board meeting approving audited financial statements for the quarter and year ended March 31, 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_dividend_did_Nureca_declare_for_FY26\"><\/span><strong>What dividend did Nureca declare for FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dividend details for Nureca FY26 are available in the BSE\/NSE audited filing. Investors should check the filing for record date and payout schedule.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Nureca_a_good_stock_to_buy_after_Q4_FY26_results\"><\/span><strong>Is Nureca a good stock to buy after Q4 FY26 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investment decisions require assessment of fundamentals, valuation, sector outlook, and personal risk tolerance. Consult a SEBI-registered financial advisor before making any investment in Nureca.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_FY27_outlook_for_Nureca\"><\/span><strong>What is the FY27 outlook for Nureca?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Following Nureca Q4 FY26 results, management guidance on revenue growth, margin improvement, and capital allocation will shape the FY27 outlook. Monitor BSE\/NSE filings and management commentary for updates.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nureca Q4 FY26 results declared May 29, 2026. Net Profit Rs 32.31 Cr. Key highlights, business performance and FY27 outlook.<\/p>\n","protected":false},"author":35,"featured_media":103246,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3858],"class_list":["post-102933","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-q4-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1780310248:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["81"],"rank_math_title":["Nureca Q4 FY26: Net Profit Rs 32.31 Crore, Key Highlights"],"rank_math_description":["Nureca Q4 FY26 results declared May 29, 2026. Net Profit Rs 32.31 Cr. Key highlights, business performance and FY27 outlook."],"rank_math_focus_keyword":["Nureca Q4 FY26"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["103246"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["14670"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Nureca-Q4.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/102933","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=102933"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/102933\/revisions"}],"predecessor-version":[{"id":103248,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/102933\/revisions\/103248"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/103246"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=102933"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=102933"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=102933"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}